Abstract
Rotaviruses (RV) are the main agents of gastroenteritis in children worldwide, resulting in high morbidity and mortality, especially in developing countries. Since the 1980s, has been intensive research to develop effective vaccines against RV. In Brazil, at the year 2006, occurred the licensing of Rotarix vaccine containing attenuated RV with genotype G1P [8], which is the most prevalent…